In CRC cells, SIRT5 promotes colorectal carcinogenesis by enhancing glutamine catabolism through activation of glutamate dehydrogenase 1 (GLUD1) in a deglutecosylation-dependent manner 204. Here, SIRT5 is linked to colorectal carcinoma.